Lupin is ranked 9th amongst global generic companies. Backing this performance is one the most vertically integrated pharmaceutical operations in the world, a key differentiator that has led to Lupin's emergence as a market leader. The company today operates a globally integrated network of 11 manufacturing facilities spread across India and Japan. World class facilities that are manufacturing and delivering products in line with and in constant compliance with quality, safety and environment standards as laid down by governments and leading regulators like the US FDA, UK MHRA, World Health Organization, Australian TGA, Indian FDA and Japan's MHLW. During FY 2012, Lupin facilities at Ankleshwar, Aurangabad, Tarapur, Mandideep and Goa were successfully audited by several of these global regulatory agencies.
At Lupin we have not only been consistently investing in ramping up our operations and creating new facilities but also ensuring that our global manufacturing organization is in sync with our global business roadmap and also with most leading global requirements.
A manufacturing organization which is consistently meeting customer demands, balancing efficiencies and focused on constant revenue enhancement as well as cost containment.An organization which is swift and agile and a setup that is engineered to deliver best quality products to our customers on a reliable basis.
Productivity and Profitability are the governing maxims for Lupin's manufacturing operations. Growth in productivity and the creation of better efficiencies are pre-conditions that go into designing and creating efficient processes. We have a uniform global process framework that ensures consistency and reproducibility. Lupin is currently working with the best consulting think tanks to integrate and implement methodologies such as lean six sigma and lean manufacturing into its global manufacturing operations. Six Sigma is a disciplined, data-driven approach and methodology for eliminating defects and maximizing efficiencies.